Advanced search

Report side effect

Report a suspected side effect or falsified product to the MHRA Yellow Card scheme.
Go to {yellow_card_logo} site
{arrow_up} Back to top

Zynlonta, 10mg, powder for concentrate for solution for infusion {equilateral_black_triangle}

Active Ingredient:
loncastuximab tesirine
Company:  
Swedish Orphan Biovitrum Ltd See contact details
ATC code: 
L01FX22
{info_black}
About Medicine
{medical_services}
Prescription only medicine
Healthcare Professionals (SmPC) Patient Leaflet (PIL) Risk Materials HCP Med Info
{arrow_left}
{arrow_right}
The Patient Information Leaflet (PIL) is the leaflet included in the pack with a medicine.
{info_black}
Last updated on emc: 12 May 2023

{equilateral_black_triangle} This medicinal product is subject to additional monitoring. This will allow quick identification of new safety information.

{pdf} View or print the patient leaflet as PDF
Swedish Orphan Biovitrum Ltd
Company image
Address
Suite 2, Riverside 3, Granta Park, Great Abington,, Cambridgeshire, CB21 6AD, UK
WWW
http://www.sobi.com
Telephone
+44 (0) 1223 891854
Medical Information Direct Line
+44 (0) 800 111 4754
Medical Information e-mail
[email protected]
Customer Care direct line
+44 (0) 800 111 4754